Skip to main content
Min Shi, MD, Pathology, Rochester, MN

MinShiMD

Pathology Rochester, MN

Hematopathology, Anatomic Pathology, Clinical Pathology

Instructor, Psychiatry & Psychology, Mayo Med Sch

Dr. Shi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Shi's full profile

Already have an account?

  • Office

    200 1st St Sw
    Medical Staff Svcs
    Rochester, MN 55905
    Phone+1 507-284-2511

Education & Training

  • UMass Chan Medical School
    UMass Chan Medical SchoolResidency, Pathology-Anatomic and Clinical, 2009 - 2013
  • Beijing Medical University
    Beijing Medical UniversityClass of 1996

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2014 - 2025
  • MA State Medical License
    MA State Medical License 2013 - 2016
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Pathology - Hematology

Publications & Presentations

PubMed

Abstracts/Posters

  • Single-Antibody Detection of T-Cell Receptor Beta Chain Monotypia Resolves Uncertainties in the Identification and Quantitation of S_zary Cells By Routine Flow Cytomet...
    Min Shi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • A Randomized Phase 2 Study Comparing Acalabrutinib with or without Obinutuzumab in the Treatment of Early Stage High Risk Patients with Chronic Lymphocytic Leukemia (C...
    Min Shi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Effects of Voxelotor (GBT440) Therapy on Laboratory Testing of Sickle Cell Patients
    Min Shi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Press Mentions

  • Adipocytes Fuel Gastric Cancer Omental Metastasis via PITPNC1-Mediated Fatty Acid Metabolic Reprogramming
    Adipocytes Fuel Gastric Cancer Omental Metastasis via PITPNC1-Mediated Fatty Acid Metabolic ReprogrammingOctober 29th, 2018